xupper22的个人主页 - 老虎社区

xupper22

xupper22

暂无个人介绍

IP属地：未知

8关注

6粉丝

2主题

0勋章

2021-12-08

Anything coming from Pfizer is bs at this point. We need actual peer reviewed studies published publicly from actual scientists for accurate information. This is just them winning back the market's confidence and persuading nations to order 3rd jabs for more profit$.

Pfizer, BioNTech say third dose neutralizes Omicron variant<blockquote>辉瑞、BioNTech 表示第三剂疫苗中和了奥密克戎变种</blockquote>

2021-12-06

$Roundhill Ball Metaverse ETF(META)$Don't panic amongst commoner fears. Buy the dip.

2021-12-06

Speculation play...

CF Acquisition Corp VI stock jumped 31% in premarket trading<blockquote>CF Acquisition Corp VI 股票在盘前交易中上涨 31%</blockquote>

2021-11-08

Last November?! Where was this in mainstream media all this time?!

Regeneron shares rose 2.2% in premarket trading<blockquote>再生元股价在盘前交易中上涨 2.2%</blockquote>

2021-11-04

The more truth about this covid situation gets spread out there, the more big corrupt pharmas should dive in the short term.

Pharmaceutical stocks dropped in premarket trading<blockquote>制药股在盘前交易中下跌</blockquote>

2021-10-30

Niiice

@小虎活动:[Halloween Game] Trade or Treat!

2021-10-30

$ABF SG BOND ETF(A35.SI)$sg is garbage

2021-10-28

Seriously last night insider pump and dump? $AST SpaceMobile, Inc.(ASTS)$

2021-10-21

Like near you

Tesla beats Q3 revenue estimates but supply-chain problems impacting factories<blockquote>特斯拉第三季度收入超出预期，但供应链问题影响工厂</blockquote>

2021-10-01

Rather great news. First aim is to tahan the rest of this year in SG without getting jabbed.

抱歉，原内容已删除

2021-09-24

$STI ETF(ES3.SI)$bloodshed

2021-09-07

$Vanguard Total Stock Market Index Fund ETF Shares(VTI)$fundamentals

2021-09-03

$Econ Healthcare(EHG.SI)$ridiculous.............

2021-07-29

$Viomi Technology Co.(VIOT)$it's a big rip

2021-07-08

Hmmm

抱歉，原内容已删除

2021-07-07

$AST SpaceMobile, Inc.(ASTS)$investing in the future

2021-06-18

$Viomi Technology Co.(VIOT)$good vibes

2021-06-16

$Angelalign Technology Inc.(06699)$wow hmm

2021-06-11

$AMC Entertainment(AMC)$appreciate a free like :)

2021-06-10

$Viomi Technology Co.(VIOT)$rip the recent gains.. wwe're going back down

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3579827147050987","uuid":"3579827147050987","gmtCreate":1616733122995,"gmtModify":1620384637938,"name":"xupper22","pinyin":"xupper22","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":6,"headSize":8,"tweetSize":26,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":2,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.04.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.12.20","exceedPercentage":"80.69%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":602303058,"gmtCreate":1638966793507,"gmtModify":1638968906662,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579827147050987","idStr":"3579827147050987"},"themes":[],"title":"","htmlText":"Anything coming from Pfizer is bs at this point. We need actual peer reviewed studies published publicly from actual scientists for accurate information. This is just them winning back the market's confidence and persuading nations to order 3rd jabs for more profit$.","listText":"Anything coming from Pfizer is bs at this point. We need actual peer reviewed studies published publicly from actual scientists for accurate information. This is just them winning back the market's confidence and persuading nations to order 3rd jabs for more profit$.","text":"Anything coming from Pfizer is bs at this point. We need actual peer reviewed studies published publicly from actual scientists for accurate information. This is just them winning back the market's confidence and persuading nations to order 3rd jabs for more profit$.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602303058","repostId":"1177589023","repostType":2,"repost":{"id":"1177589023","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638964838,"share":"https://www.laohunote.com/m/news/1177589023?lang=zh_CN&edition=full","pubTime":"2021-12-08 20:00","market":"us","language":"en","title":"Pfizer, BioNTech say third dose neutralizes Omicron variant<blockquote>辉瑞、BioNTech 表示第三剂疫苗中和了奥密克戎变种</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1177589023","media":"Tiger Newspress","summary":"Pfizer and biontech stocks narrowed their losses in premarket trading after they provided update on ","content":"<p>Pfizer and biontech stocks narrowed their losses&nbsp;in premarket trading&nbsp;after&nbsp;they provided update on Omicron variant.</p><p><blockquote>辉瑞和 biontech 股票在提供有关奥密克戎变种的最新信息后，在盘前交易中缩小了跌幅。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/896ce4e657b0942d9d7a0abce1c3d2f7\" tg-width=\"853\" tg-height=\"622\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/35c4bf42aa2936640aedd52e01beebc5\" tg-width=\"853\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <ul>  <li><i>Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers</i></li>  <li><i>Data indicate that a third dose of BNT162b2 increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant; titers after the booster dose are comparable to titers observed after two doses against the wild-type virus which are associated with high levels of protection</i></li>  <li><i>As 80% of epitopes in the spike protein recognized by CD8+ T cells are not affected by the mutations in the Omicron variant, two doses may still induce protection against severe disease</i></li>  <li><i>The companies continue to advance the development of a variant-specific vaccine for Omicron and expect to have it available by March in the event that an adaption is needed to further increase the level and duration of protection – with no change expected to the companies’ four billion dose capacity for 2022</i></li> </ul> Pfizer Inc.&nbsp;and&nbsp;BioNTech SE&nbsp;today announced results from an initial&nbsp;<i>laboratory</i>&nbsp;study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 Omicron variant after three doses. Sera obtained from vaccinees one month after receiving the booster vaccination (third dose of BNT162b2 vaccine) neutralized the Omicron variant to levels that are comparable to thoseobserved for the wild-type SARS-CoV-2 spike protein after two doses.</p><p><blockquote><ul><li><i>初步实验室研究表明，三剂辉瑞-BioNTech新冠肺炎疫苗中和奥密克戎变异株（B.1.1.529谱系），而两剂显示出中和滴度显著降低</i></li><li><i>数据表明，与针对奥密克戎变体的两个剂量相比，第三剂量的BNT162b2将中和抗体滴度增加25倍；加强剂量后的滴度与针对野生型病毒的两次剂量后观察到的滴度相当，这与高水平的保护相关</i></li><li><i>由于CD8+T细胞识别的刺突蛋白中80%的表位不受奥密克戎变体中突变的影响，两个剂量仍然可以诱导对严重疾病的保护</i></li><li><i>两家公司将继续推进针对奥密克戎病毒的变种特异性疫苗的开发，如果需要进行调整以进一步提高保护水平和持续时间，预计将于 3 月份上市--预计两家公司 2022 年 40 亿剂疫苗的产能不会发生变化。</i></li></ul>辉瑞公司和 BioNTech SE 今天公布了初步结果<i>实验室</i>研究表明，辉瑞-BioNTech新冠肺炎疫苗（BNT162b2）诱导的血清抗体在接种三剂后中和新型冠状病毒奥密克戎变体。在接受加强疫苗接种（第三剂BNT162b2疫苗）一个月后从接种者获得的血清中和了奥密克戎变异体，其水平与两剂后野生型新型冠状病毒刺突蛋白相当。</blockquote></p><p> Sera from individuals who received two doses of the current COVID-19 vaccine did exhibit, on average, more than a 25-fold reduction in neutralization titers against the Omicron variant compared to wild-type, indicating that two doses of BNT162b2 may not be sufficient to protect against infection with the Omicron variant. However, as the vast majority of epitopes targeted by vaccine-induced T cells are not affected by the mutations in Omicron, the companies believe that vaccinated individuals may still be protected against severe forms of the disease and are closely monitoring real world effectiveness against Omicron, globally.</p><p><blockquote>与野生型相比，接受两剂当前新冠肺炎疫苗的个体的血清确实显示，与野生型相比，针对奥密克戎变体的中和滴度平均降低了25倍以上，这表明两剂BNT162b2可能不足以预防感染奥密克戎变体。然而，由于疫苗诱导的T细胞靶向的绝大多数表位不受奥密克戎突变的影响，这些公司认为，接种疫苗的个体仍然可以免受严重形式的疾病的侵害，并正在密切监测全球范围内针对奥密克戎的现实效果。</blockquote></p><p> A more robust protection may be achieved by a third dose as data from additional studies of the companies indicate that a booster with the current COVID-19 vaccine from Pfizer and BioNTech increases the antibody titers by 25-fold. According to the companies’ preliminary data, a third dose provides a similar level of neutralizing antibodies to Omicron as is observed after two doses against wild-type and other variants that emerged before Omicron. These antibody levels are associated with high efficacy against both the wild-type virus and these variants. A third dose also strongly increases CD8+T cell levels against multiple spike protein epitopes which are considered to correlate with the protection against severe disease. Compared to the wild-type virus, the vast majority of these epitopes remain unchanged in the Omicron spike variant.</p><p><blockquote>第三剂可以实现更强大的保护，因为两家公司的其他研究数据表明，辉瑞和 BioNTech 当前 COVID-19 疫苗的加强剂可将抗体滴度提高 25 倍。根据两家公司的初步数据，第三剂疫苗对奥密克戎病毒的中和抗体水平与对野生型病毒和奥密克戎病毒之前出现的其他变种疫苗接种两剂疫苗后观察到的水平相似。这些抗体水平与针对野生型病毒和这些变体的高功效相关。第三剂还强烈增加针对多个刺突蛋白表位的CD8+T细胞水平，这些刺突蛋白表位被认为与对严重疾病的保护相关。与野生型病毒相比，这些表位的绝大多数在奥密克戎刺突变体中保持不变。</blockquote></p><p> “Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is improved with a third dose of our vaccine,” said&nbsp;<b>Albert Bourla, Chairman and Chief Executive Officer, Pfizer</b>. “Ensuring as many people as possible are fully vaccinated with the first two dose series and a booster remains the best course of action to prevent the spread of COVID-19.”</p><p><blockquote>“虽然接种两剂疫苗仍能预防奥密克戎毒株引起的严重疾病，但从这些初步数据来看，接种第三剂疫苗可以提高保护能力，”他说。<b>Albert Bourla，辉瑞公司董事长兼首席执行官</b>. “确保尽可能多的人完全接种前两剂疫苗和加强针仍然是防止 COVID-19 传播的最佳行动方案”。</blockquote></p><p> “Our preliminary, first dataset indicate that a third dose could still offer a sufficient level of protection from disease of any severity caused by the Omicron variant,” said&nbsp;<b>Ugur Sahin, M.D., CEO and Co-Founder of BioNTech</b>. “Broad vaccination and booster campaigns around the world could help us to better protect people everywhere and to get through the winter season. We continue to work on an adapted vaccine which, we believe, will help to induce a high level of protection against Omicron-induced COVID-19 disease as well as a prolonged protection compared to the current vaccine.”</p><p><blockquote>“我们初步的第一批数据集表明，第三剂疫苗仍能提供足够的保护，预防奥密克戎变异株引起的任何严重程度的疾病。”<b>Ugur Sahin，医学博士，BioNTech 首席执行官兼联合创始人</b>. “在世界各地开展广泛的疫苗接种和加强运动可以帮助我们更好地保护各地的人们，并帮助他们度过冬季。我们将继续研发一种经过改造的疫苗，我们相信，与目前的疫苗相比，这种疫苗将有助于对奥密克戎引起的 COVID-19 疾病产生高水平的保护作用，并提供更持久的保护”。</blockquote></p><p></p><p> While these results are preliminary, the companies will continue to collect more laboratory data and evaluate real-world effectiveness to assess and confirm protection against Omicron and inform the most effective path forward. On November 25, the companies started to develop an Omicron-specific COVID-19 vaccine. The development will continue as planned in the event that a vaccine adaption is needed to increase the level and duration of protection against Omicron. First batches of the Omicron-based vaccine can be produced and are planned to be ready for deliveries within 100 days, pending regulatory approval. Pfizer and BioNTech have tested other variant-specific vaccines as well, which have produced very strong neutralization titers and a tolerable safety profile. Based on this experience the companies have high confidence that if needed they can deliver an Omicron-based vaccine in March 2022. The companies have also previously initiated clinical trials with variant-specific vaccines (Alpha, Beta, Delta &amp; Alpha/Delta Mix) and data from these studies will be submitted to regulatory agencies around the world to help accelerate the process of adapting the vaccine and gaining regulatory authorization or approval of an Omicron-specific vaccine, if needed. The companies have previously announced that they expect to produce four billion doses of BNT162b2 in 2022, and this capacity is not expected to change if an adapted vaccine is required.</p><p><blockquote>虽然这些结果是初步的，但这些公司将继续收集更多的实验室数据并评估现实世界的有效性，以评估和确认对奥密克戎的保护，并为最有效的前进道路提供信息。11月25日，两家公司开始开发奥密克戎特异性新冠肺炎疫苗。如果需要调整疫苗以提高对奥密克戎的保护水平和持续时间，开发将按计划继续进行。第一批总部位于奥密克戎的疫苗可以生产，并计划在100天内准备好交付，等待监管部门的批准。辉瑞和BioNTech也测试了其他变异特异性疫苗，这些疫苗产生了非常强的中和滴度和可耐受的安全性。基于这一经验，这些公司非常有信心，如果需要的话，他们可以在2022年3月交付基于奥密克戎的疫苗。这些公司此前还启动了变异特异性疫苗（Alpha、Beta、DeltaΑ/Delta混合）的临床试验，这些研究的数据将提交给世界各地的监管机构，以帮助加快疫苗的适应过程，并在需要时获得奥密克戎特异性疫苗的监管授权或批准。这两家公司此前曾宣布，他们预计将在2022年生产40亿剂BNT162b2，如果需要适应的疫苗，这一产能预计不会改变。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer, BioNTech say third dose neutralizes Omicron variant<blockquote>辉瑞、BioNTech 表示第三剂疫苗中和了奥密克戎变种</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer, BioNTech say third dose neutralizes Omicron variant<blockquote>辉瑞、BioNTech 表示第三剂疫苗中和了奥密克戎变种</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-08 20:00</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Pfizer and biontech stocks narrowed their losses&nbsp;in premarket trading&nbsp;after&nbsp;they provided update on Omicron variant.</p><p><blockquote>辉瑞和 biontech 股票在提供有关奥密克戎变种的最新信息后，在盘前交易中缩小了跌幅。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/896ce4e657b0942d9d7a0abce1c3d2f7\" tg-width=\"853\" tg-height=\"622\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/35c4bf42aa2936640aedd52e01beebc5\" tg-width=\"853\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <ul>  <li><i>Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers</i></li>  <li><i>Data indicate that a third dose of BNT162b2 increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant; titers after the booster dose are comparable to titers observed after two doses against the wild-type virus which are associated with high levels of protection</i></li>  <li><i>As 80% of epitopes in the spike protein recognized by CD8+ T cells are not affected by the mutations in the Omicron variant, two doses may still induce protection against severe disease</i></li>  <li><i>The companies continue to advance the development of a variant-specific vaccine for Omicron and expect to have it available by March in the event that an adaption is needed to further increase the level and duration of protection – with no change expected to the companies’ four billion dose capacity for 2022</i></li> </ul> Pfizer Inc.&nbsp;and&nbsp;BioNTech SE&nbsp;today announced results from an initial&nbsp;<i>laboratory</i>&nbsp;study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 Omicron variant after three doses. Sera obtained from vaccinees one month after receiving the booster vaccination (third dose of BNT162b2 vaccine) neutralized the Omicron variant to levels that are comparable to thoseobserved for the wild-type SARS-CoV-2 spike protein after two doses.</p><p><blockquote><ul><li><i>初步实验室研究表明，三剂辉瑞-BioNTech新冠肺炎疫苗中和奥密克戎变异株（B.1.1.529谱系），而两剂显示出中和滴度显著降低</i></li><li><i>数据表明，与针对奥密克戎变体的两个剂量相比，第三剂量的BNT162b2将中和抗体滴度增加25倍；加强剂量后的滴度与针对野生型病毒的两次剂量后观察到的滴度相当，这与高水平的保护相关</i></li><li><i>由于CD8+T细胞识别的刺突蛋白中80%的表位不受奥密克戎变体中突变的影响，两个剂量仍然可以诱导对严重疾病的保护</i></li><li><i>两家公司将继续推进针对奥密克戎病毒的变种特异性疫苗的开发，如果需要进行调整以进一步提高保护水平和持续时间，预计将于 3 月份上市--预计两家公司 2022 年 40 亿剂疫苗的产能不会发生变化。</i></li></ul>辉瑞公司和 BioNTech SE 今天公布了初步结果<i>实验室</i>研究表明，辉瑞-BioNTech新冠肺炎疫苗（BNT162b2）诱导的血清抗体在接种三剂后中和新型冠状病毒奥密克戎变体。在接受加强疫苗接种（第三剂BNT162b2疫苗）一个月后从接种者获得的血清中和了奥密克戎变异体，其水平与两剂后野生型新型冠状病毒刺突蛋白相当。</blockquote></p><p> Sera from individuals who received two doses of the current COVID-19 vaccine did exhibit, on average, more than a 25-fold reduction in neutralization titers against the Omicron variant compared to wild-type, indicating that two doses of BNT162b2 may not be sufficient to protect against infection with the Omicron variant. However, as the vast majority of epitopes targeted by vaccine-induced T cells are not affected by the mutations in Omicron, the companies believe that vaccinated individuals may still be protected against severe forms of the disease and are closely monitoring real world effectiveness against Omicron, globally.</p><p><blockquote>与野生型相比，接受两剂当前新冠肺炎疫苗的个体的血清确实显示，与野生型相比，针对奥密克戎变体的中和滴度平均降低了25倍以上，这表明两剂BNT162b2可能不足以预防感染奥密克戎变体。然而，由于疫苗诱导的T细胞靶向的绝大多数表位不受奥密克戎突变的影响，这些公司认为，接种疫苗的个体仍然可以免受严重形式的疾病的侵害，并正在密切监测全球范围内针对奥密克戎的现实效果。</blockquote></p><p> A more robust protection may be achieved by a third dose as data from additional studies of the companies indicate that a booster with the current COVID-19 vaccine from Pfizer and BioNTech increases the antibody titers by 25-fold. According to the companies’ preliminary data, a third dose provides a similar level of neutralizing antibodies to Omicron as is observed after two doses against wild-type and other variants that emerged before Omicron. These antibody levels are associated with high efficacy against both the wild-type virus and these variants. A third dose also strongly increases CD8+T cell levels against multiple spike protein epitopes which are considered to correlate with the protection against severe disease. Compared to the wild-type virus, the vast majority of these epitopes remain unchanged in the Omicron spike variant.</p><p><blockquote>第三剂可以实现更强大的保护，因为两家公司的其他研究数据表明，辉瑞和 BioNTech 当前 COVID-19 疫苗的加强剂可将抗体滴度提高 25 倍。根据两家公司的初步数据，第三剂疫苗对奥密克戎病毒的中和抗体水平与对野生型病毒和奥密克戎病毒之前出现的其他变种疫苗接种两剂疫苗后观察到的水平相似。这些抗体水平与针对野生型病毒和这些变体的高功效相关。第三剂还强烈增加针对多个刺突蛋白表位的CD8+T细胞水平，这些刺突蛋白表位被认为与对严重疾病的保护相关。与野生型病毒相比，这些表位的绝大多数在奥密克戎刺突变体中保持不变。</blockquote></p><p> “Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is improved with a third dose of our vaccine,” said&nbsp;<b>Albert Bourla, Chairman and Chief Executive Officer, Pfizer</b>. “Ensuring as many people as possible are fully vaccinated with the first two dose series and a booster remains the best course of action to prevent the spread of COVID-19.”</p><p><blockquote>“虽然接种两剂疫苗仍能预防奥密克戎毒株引起的严重疾病，但从这些初步数据来看，接种第三剂疫苗可以提高保护能力，”他说。<b>Albert Bourla，辉瑞公司董事长兼首席执行官</b>. “确保尽可能多的人完全接种前两剂疫苗和加强针仍然是防止 COVID-19 传播的最佳行动方案”。</blockquote></p><p> “Our preliminary, first dataset indicate that a third dose could still offer a sufficient level of protection from disease of any severity caused by the Omicron variant,” said&nbsp;<b>Ugur Sahin, M.D., CEO and Co-Founder of BioNTech</b>. “Broad vaccination and booster campaigns around the world could help us to better protect people everywhere and to get through the winter season. We continue to work on an adapted vaccine which, we believe, will help to induce a high level of protection against Omicron-induced COVID-19 disease as well as a prolonged protection compared to the current vaccine.”</p><p><blockquote>“我们初步的第一批数据集表明，第三剂疫苗仍能提供足够的保护，预防奥密克戎变异株引起的任何严重程度的疾病。”<b>Ugur Sahin，医学博士，BioNTech 首席执行官兼联合创始人</b>. “在世界各地开展广泛的疫苗接种和加强运动可以帮助我们更好地保护各地的人们，并帮助他们度过冬季。我们将继续研发一种经过改造的疫苗，我们相信，与目前的疫苗相比，这种疫苗将有助于对奥密克戎引起的 COVID-19 疾病产生高水平的保护作用，并提供更持久的保护”。</blockquote></p><p></p><p> While these results are preliminary, the companies will continue to collect more laboratory data and evaluate real-world effectiveness to assess and confirm protection against Omicron and inform the most effective path forward. On November 25, the companies started to develop an Omicron-specific COVID-19 vaccine. The development will continue as planned in the event that a vaccine adaption is needed to increase the level and duration of protection against Omicron. First batches of the Omicron-based vaccine can be produced and are planned to be ready for deliveries within 100 days, pending regulatory approval. Pfizer and BioNTech have tested other variant-specific vaccines as well, which have produced very strong neutralization titers and a tolerable safety profile. Based on this experience the companies have high confidence that if needed they can deliver an Omicron-based vaccine in March 2022. The companies have also previously initiated clinical trials with variant-specific vaccines (Alpha, Beta, Delta &amp; Alpha/Delta Mix) and data from these studies will be submitted to regulatory agencies around the world to help accelerate the process of adapting the vaccine and gaining regulatory authorization or approval of an Omicron-specific vaccine, if needed. The companies have previously announced that they expect to produce four billion doses of BNT162b2 in 2022, and this capacity is not expected to change if an adapted vaccine is required.</p><p><blockquote>虽然这些结果是初步的，但这些公司将继续收集更多的实验室数据并评估现实世界的有效性，以评估和确认对奥密克戎的保护，并为最有效的前进道路提供信息。11月25日，两家公司开始开发奥密克戎特异性新冠肺炎疫苗。如果需要调整疫苗以提高对奥密克戎的保护水平和持续时间，开发将按计划继续进行。第一批总部位于奥密克戎的疫苗可以生产，并计划在100天内准备好交付，等待监管部门的批准。辉瑞和BioNTech也测试了其他变异特异性疫苗，这些疫苗产生了非常强的中和滴度和可耐受的安全性。基于这一经验，这些公司非常有信心，如果需要的话，他们可以在2022年3月交付基于奥密克戎的疫苗。这些公司此前还启动了变异特异性疫苗（Alpha、Beta、DeltaΑ/Delta混合）的临床试验，这些研究的数据将提交给世界各地的监管机构，以帮助加快疫苗的适应过程，并在需要时获得奥密克戎特异性疫苗的监管授权或批准。这两家公司此前曾宣布，他们预计将在2022年生产40亿剂BNT162b2，如果需要适应的疫苗，这一产能预计不会改变。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1177589023","content_text":"Pfizer and biontech stocks narrowed their losses in premarket trading after they provided update on Omicron variant.\n\n\nPreliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers\nData indicate that a third dose of BNT162b2 increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant; titers after the booster dose are comparable to titers observed after two doses against the wild-type virus which are associated with high levels of protection\nAs 80% of epitopes in the spike protein recognized by CD8+ T cells are not affected by the mutations in the Omicron variant, two doses may still induce protection against severe disease\nThe companies continue to advance the development of a variant-specific vaccine for Omicron and expect to have it available by March in the event that an adaption is needed to further increase the level and duration of protection – with no change expected to the companies’ four billion dose capacity for 2022\n\nPfizer Inc. and BioNTech SE today announced results from an initial laboratory study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 Omicron variant after three doses. Sera obtained from vaccinees one month after receiving the booster vaccination (third dose of BNT162b2 vaccine) neutralized the Omicron variant to levels that are comparable to thoseobserved for the wild-type SARS-CoV-2 spike protein after two doses.\nSera from individuals who received two doses of the current COVID-19 vaccine did exhibit, on average, more than a 25-fold reduction in neutralization titers against the Omicron variant compared to wild-type, indicating that two doses of BNT162b2 may not be sufficient to protect against infection with the Omicron variant. However, as the vast majority of epitopes targeted by vaccine-induced T cells are not affected by the mutations in Omicron, the companies believe that vaccinated individuals may still be protected against severe forms of the disease and are closely monitoring real world effectiveness against Omicron, globally.\nA more robust protection may be achieved by a third dose as data from additional studies of the companies indicate that a booster with the current COVID-19 vaccine from Pfizer and BioNTech increases the antibody titers by 25-fold. According to the companies’ preliminary data, a third dose provides a similar level of neutralizing antibodies to Omicron as is observed after two doses against wild-type and other variants that emerged before Omicron. These antibody levels are associated with high efficacy against both the wild-type virus and these variants. A third dose also strongly increases CD8+T cell levels against multiple spike protein epitopes which are considered to correlate with the protection against severe disease. Compared to the wild-type virus, the vast majority of these epitopes remain unchanged in the Omicron spike variant.\n“Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is improved with a third dose of our vaccine,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “Ensuring as many people as possible are fully vaccinated with the first two dose series and a booster remains the best course of action to prevent the spread of COVID-19.”\n“Our preliminary, first dataset indicate that a third dose could still offer a sufficient level of protection from disease of any severity caused by the Omicron variant,” said Ugur Sahin, M.D., CEO and Co-Founder of BioNTech. “Broad vaccination and booster campaigns around the world could help us to better protect people everywhere and to get through the winter season. We continue to work on an adapted vaccine which, we believe, will help to induce a high level of protection against Omicron-induced COVID-19 disease as well as a prolonged protection compared to the current vaccine.”\nWhile these results are preliminary, the companies will continue to collect more laboratory data and evaluate real-world effectiveness to assess and confirm protection against Omicron and inform the most effective path forward. On November 25, the companies started to develop an Omicron-specific COVID-19 vaccine. The development will continue as planned in the event that a vaccine adaption is needed to increase the level and duration of protection against Omicron. First batches of the Omicron-based vaccine can be produced and are planned to be ready for deliveries within 100 days, pending regulatory approval. Pfizer and BioNTech have tested other variant-specific vaccines as well, which have produced very strong neutralization titers and a tolerable safety profile. Based on this experience the companies have high confidence that if needed they can deliver an Omicron-based vaccine in March 2022. The companies have also previously initiated clinical trials with variant-specific vaccines (Alpha, Beta, Delta & Alpha/Delta Mix) and data from these studies will be submitted to regulatory agencies around the world to help accelerate the process of adapting the vaccine and gaining regulatory authorization or approval of an Omicron-specific vaccine, if needed. The companies have previously announced that they expect to produce four billion doses of BNT162b2 in 2022, and this capacity is not expected to change if an adapted vaccine is required.","news_type":1,"symbols_score_info":{"PFE":0.9,"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":4271,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606014353,"gmtCreate":1638801265327,"gmtModify":1638801265468,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579827147050987","idStr":"3579827147050987"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/META\">$Roundhill Ball Metaverse ETF(META)$</a>Don't panic amongst commoner fears. Buy the dip.","listText":"<a href=\"https://laohu8.com/S/META\">$Roundhill Ball Metaverse ETF(META)$</a>Don't panic amongst commoner fears. Buy the dip.","text":"$Roundhill Ball Metaverse ETF(META)$Don't panic amongst commoner fears. Buy the dip.","images":[{"img":"https://static.tigerbbs.com/b0e398f47591254152b057b8cb9f72fa","width":"1440","height":"2560"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606014353","isVote":1,"tweetType":1,"viewCount":3642,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":608798676,"gmtCreate":1638787262028,"gmtModify":1638787262432,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579827147050987","idStr":"3579827147050987"},"themes":[],"title":"","htmlText":"Speculation play...","listText":"Speculation play...","text":"Speculation play...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608798676","repostId":"1191547402","repostType":2,"repost":{"id":"1191547402","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638783371,"share":"https://www.laohunote.com/m/news/1191547402?lang=zh_CN&edition=full","pubTime":"2021-12-06 17:36","market":"us","language":"en","title":"CF Acquisition Corp VI stock jumped 31% in premarket trading<blockquote>CF Acquisition Corp VI 股票在盘前交易中上涨 31%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1191547402","media":"Tiger Newspress","summary":"CF Acquisition Corp VI stock jumped 31% in premarket trading as YouTube competitor Rumble would go p","content":"<p>CF Acquisition Corp VI stock jumped 31% in premarket trading&nbsp;as&nbsp;YouTube competitor Rumble&nbsp;would&nbsp;go public via SPAC CF Acquisition VI.</p><p><blockquote>由于 YouTube 竞争对手 Rumble 将通过 SPAC CF Acquisition VI 上市，CF Acquisition Corp VI 股价在盘前交易中上涨 31%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/b8dc893dd9a925f906f6e5709286bb79\" tg-width=\"850\" tg-height=\"620\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Canadian video platform Rumble Inc said&nbsp;it would go public by merging with blank-check firm&nbsp;CF Acquisition Corp VI&nbsp;at an initial enterprise value of $2.1 billion.</p><p><blockquote>加拿大视频平台 Rumble Inc 表示，将通过与空白支票公司 CF Acquisition Corp VI 合并上市，初始企业价值为 21 亿美元。</blockquote></p><p> The deal is expected to provide about $400 million in proceeds to Rumble, the company said in a statement.</p><p><blockquote>该公司在一份声明中表示，这笔交易预计将为 Rumble 提供约 4 亿美元的收益。</blockquote></p><p> Upon the deal's closing, Rumble said founder and Chief Executive Officer Chris Pavlovski will retain voting control.</p><p><blockquote>交易完成后，Rumble 表示创始人兼首席执行官克里斯·帕夫洛夫斯基 (Chris Pavlovski) 将保留投票控制权。</blockquote></p><p> The combined company will be called Rumble and is expected to list on the Nasdaq.</p><p><blockquote>合并后的公司将被命名为Rumble，预计将在纳斯达克上市。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CF Acquisition Corp VI stock jumped 31% in premarket trading<blockquote>CF Acquisition Corp VI 股票在盘前交易中上涨 31%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCF Acquisition Corp VI stock jumped 31% in premarket trading<blockquote>CF Acquisition Corp VI 股票在盘前交易中上涨 31%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-06 17:36</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>CF Acquisition Corp VI stock jumped 31% in premarket trading&nbsp;as&nbsp;YouTube competitor Rumble&nbsp;would&nbsp;go public via SPAC CF Acquisition VI.</p><p><blockquote>由于 YouTube 竞争对手 Rumble 将通过 SPAC CF Acquisition VI 上市，CF Acquisition Corp VI 股价在盘前交易中上涨 31%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/b8dc893dd9a925f906f6e5709286bb79\" tg-width=\"850\" tg-height=\"620\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Canadian video platform Rumble Inc said&nbsp;it would go public by merging with blank-check firm&nbsp;CF Acquisition Corp VI&nbsp;at an initial enterprise value of $2.1 billion.</p><p><blockquote>加拿大视频平台 Rumble Inc 表示，将通过与空白支票公司 CF Acquisition Corp VI 合并上市，初始企业价值为 21 亿美元。</blockquote></p><p> The deal is expected to provide about $400 million in proceeds to Rumble, the company said in a statement.</p><p><blockquote>该公司在一份声明中表示，这笔交易预计将为 Rumble 提供约 4 亿美元的收益。</blockquote></p><p> Upon the deal's closing, Rumble said founder and Chief Executive Officer Chris Pavlovski will retain voting control.</p><p><blockquote>交易完成后，Rumble 表示创始人兼首席执行官克里斯·帕夫洛夫斯基 (Chris Pavlovski) 将保留投票控制权。</blockquote></p><p> The combined company will be called Rumble and is expected to list on the Nasdaq.</p><p><blockquote>合并后的公司将被命名为Rumble，预计将在纳斯达克上市。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191547402","content_text":"CF Acquisition Corp VI stock jumped 31% in premarket trading as YouTube competitor Rumble would go public via SPAC CF Acquisition VI.\n\nCanadian video platform Rumble Inc said it would go public by merging with blank-check firm CF Acquisition Corp VI at an initial enterprise value of $2.1 billion.\nThe deal is expected to provide about $400 million in proceeds to Rumble, the company said in a statement.\nUpon the deal's closing, Rumble said founder and Chief Executive Officer Chris Pavlovski will retain voting control.\nThe combined company will be called Rumble and is expected to list on the Nasdaq.","news_type":1,"symbols_score_info":{"CFVI":0.9}},"isVote":1,"tweetType":1,"viewCount":3862,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844019974,"gmtCreate":1636376601266,"gmtModify":1636376649125,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579827147050987","idStr":"3579827147050987"},"themes":[],"title":"","htmlText":"Last November?! Where was this in mainstream media all this time?!&nbsp;","listText":"Last November?! Where was this in mainstream media all this time?!&nbsp;","text":"Last November?! Where was this in mainstream media all this time?!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844019974","repostId":"1141245956","repostType":2,"repost":{"id":"1141245956","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636375961,"share":"https://www.laohunote.com/m/news/1141245956?lang=zh_CN&edition=full","pubTime":"2021-11-08 20:52","market":"us","language":"en","title":"Regeneron shares rose 2.2% in premarket trading<blockquote>再生元股价在盘前交易中上涨 2.2%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1141245956","media":"Tiger Newspress","summary":"Regeneron shares rose 2.2% in premarket trading.\nRegeneron Pharmaceuticals Inc said on Monday a sing","content":"<p>Regeneron&nbsp;shares&nbsp;rose&nbsp;2.2%&nbsp;in&nbsp;premarket&nbsp;trading.</p><p><blockquote>再生元股价在盘前交易中上涨 2.2%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1d06980fde1a0bd99affdab9ee4beb4b\" tg-width=\"889\" tg-height=\"603\" width=\"100%\" height=\"auto\">Regeneron Pharmaceuticals Inc said on Monday a single dose of its antibody cocktail reduced the risk of contracting COVID-19 by 81.6% in the two to eight months period following the drug's administration in a late-stage trial.</p><p><blockquote>再生元制药公司周一表示，在后期试验中使用该药物后的两到八个月内，单剂量其抗体鸡尾酒可将感染 COVID-19 的风险降低 81.6%。</blockquote></p><p> The results showed that antibody therapy, REGEN-COV, has the potential to provide long-lasting immunity from COVID-19 infection, said Myron Cohen, who leads monoclonal antibody efforts for the U.S. National Institutes of Health-sponsored COVID Prevention Network.</p><p><blockquote>美国国立卫生研究院赞助的COVID预防网络单克隆抗体工作负责人迈伦·科恩说，结果表明，抗体疗法REGEN-COV有可能提供对新冠肺炎感染的持久免疫力。</blockquote></p><p> Such immunity is particularly important for immunocompromised people and those not responding to vaccines, the company said.</p><p><blockquote>该公司表示，这种免疫力对于免疫功能低下的人和对疫苗没有反应的人尤其重要。</blockquote></p><p> The therapy had previously shown&nbsp;an 81.4% risk reduction during the first month after administration.</p><p><blockquote>该疗法之前在给药后的第一个月内显示风险降低了81.4%。</blockquote></p><p> During the 8-month assessment period, there were no hospitalizations for COVID-19 in the REGEN-COV group, but in the placebo group 6 such incidents were recorded, Regeneron said.</p><p><blockquote>Regeneron 表示，在 8 个月的评估期内，REGEN-COV 组中没有因 COVID-19 住院的病例，但安慰剂组中记录了 6 起此类事件。</blockquote></p><p> The U.S. health regulator in July expanded REGEN-COV's authorization to enable its use as a preventive treatment in people exposed to infected individuals, and those at high risk of such exposure in settings such as nursing homes or prisons.</p><p><blockquote>美国卫生监管机构在7月份扩大了REGEN-COV的授权，使其能够用作接触感染者的人以及在疗养院或监狱等环境中接触感染者的高风险人群的预防性治疗。</blockquote></p><p> It was authorized in the United States last November to treat people with mild-to-moderate COVID-19 disease.</p><p><blockquote>去年11月，它在美国被授权用于治疗轻度至中度新冠肺炎疾病患者。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regeneron shares rose 2.2% in premarket trading<blockquote>再生元股价在盘前交易中上涨 2.2%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegeneron shares rose 2.2% in premarket trading<blockquote>再生元股价在盘前交易中上涨 2.2%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-08 20:52</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Regeneron&nbsp;shares&nbsp;rose&nbsp;2.2%&nbsp;in&nbsp;premarket&nbsp;trading.</p><p><blockquote>再生元股价在盘前交易中上涨 2.2%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1d06980fde1a0bd99affdab9ee4beb4b\" tg-width=\"889\" tg-height=\"603\" width=\"100%\" height=\"auto\">Regeneron Pharmaceuticals Inc said on Monday a single dose of its antibody cocktail reduced the risk of contracting COVID-19 by 81.6% in the two to eight months period following the drug's administration in a late-stage trial.</p><p><blockquote>再生元制药公司周一表示，在后期试验中使用该药物后的两到八个月内，单剂量其抗体鸡尾酒可将感染 COVID-19 的风险降低 81.6%。</blockquote></p><p> The results showed that antibody therapy, REGEN-COV, has the potential to provide long-lasting immunity from COVID-19 infection, said Myron Cohen, who leads monoclonal antibody efforts for the U.S. National Institutes of Health-sponsored COVID Prevention Network.</p><p><blockquote>美国国立卫生研究院赞助的COVID预防网络单克隆抗体工作负责人迈伦·科恩说，结果表明，抗体疗法REGEN-COV有可能提供对新冠肺炎感染的持久免疫力。</blockquote></p><p> Such immunity is particularly important for immunocompromised people and those not responding to vaccines, the company said.</p><p><blockquote>该公司表示，这种免疫力对于免疫功能低下的人和对疫苗没有反应的人尤其重要。</blockquote></p><p> The therapy had previously shown&nbsp;an 81.4% risk reduction during the first month after administration.</p><p><blockquote>该疗法之前在给药后的第一个月内显示风险降低了81.4%。</blockquote></p><p> During the 8-month assessment period, there were no hospitalizations for COVID-19 in the REGEN-COV group, but in the placebo group 6 such incidents were recorded, Regeneron said.</p><p><blockquote>Regeneron 表示，在 8 个月的评估期内，REGEN-COV 组中没有因 COVID-19 住院的病例，但安慰剂组中记录了 6 起此类事件。</blockquote></p><p> The U.S. health regulator in July expanded REGEN-COV's authorization to enable its use as a preventive treatment in people exposed to infected individuals, and those at high risk of such exposure in settings such as nursing homes or prisons.</p><p><blockquote>美国卫生监管机构在7月份扩大了REGEN-COV的授权，使其能够用作接触感染者的人以及在疗养院或监狱等环境中接触感染者的高风险人群的预防性治疗。</blockquote></p><p> It was authorized in the United States last November to treat people with mild-to-moderate COVID-19 disease.</p><p><blockquote>去年11月，它在美国被授权用于治疗轻度至中度新冠肺炎疾病患者。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"REGN":"再生元制药公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1141245956","content_text":"Regeneron shares rose 2.2% in premarket trading.\nRegeneron Pharmaceuticals Inc said on Monday a single dose of its antibody cocktail reduced the risk of contracting COVID-19 by 81.6% in the two to eight months period following the drug's administration in a late-stage trial.\nThe results showed that antibody therapy, REGEN-COV, has the potential to provide long-lasting immunity from COVID-19 infection, said Myron Cohen, who leads monoclonal antibody efforts for the U.S. National Institutes of Health-sponsored COVID Prevention Network.\nSuch immunity is particularly important for immunocompromised people and those not responding to vaccines, the company said.\nThe therapy had previously shown an 81.4% risk reduction during the first month after administration.\nDuring the 8-month assessment period, there were no hospitalizations for COVID-19 in the REGEN-COV group, but in the placebo group 6 such incidents were recorded, Regeneron said.\nThe U.S. health regulator in July expanded REGEN-COV's authorization to enable its use as a preventive treatment in people exposed to infected individuals, and those at high risk of such exposure in settings such as nursing homes or prisons.\nIt was authorized in the United States last November to treat people with mild-to-moderate COVID-19 disease.","news_type":1,"symbols_score_info":{"REGN":0.9}},"isVote":1,"tweetType":1,"viewCount":4862,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":848709368,"gmtCreate":1636025415150,"gmtModify":1636027785724,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579827147050987","idStr":"3579827147050987"},"themes":[],"title":"","htmlText":"The more truth about this covid situation gets spread out there, the more big corrupt pharmas should dive in the short term.&nbsp;","listText":"The more truth about this covid situation gets spread out there, the more big corrupt pharmas should dive in the short term.&nbsp;","text":"The more truth about this covid situation gets spread out there, the more big corrupt pharmas should dive in the short term.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848709368","repostId":"1114412462","repostType":2,"repost":{"id":"1114412462","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636024828,"share":"https://www.laohunote.com/m/news/1114412462?lang=zh_CN&edition=full","pubTime":"2021-11-04 19:20","market":"us","language":"en","title":"Pharmaceutical stocks dropped in premarket trading<blockquote>制药股在盘前交易中下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1114412462","media":"Tiger Newspress","summary":"Pharmaceutical stocks dropped in premarket trading after Moderna earnings coming in far short of est","content":"<p>Pharmaceutical stocks dropped in premarket trading&nbsp;after&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">Moderna</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">earnings</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">coming</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">in</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">far</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">short</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">of</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">estimates</a>.Moderna,Novavax&nbsp;and&nbsp;BioNTech SE&nbsp;Dived&nbsp;between 4% and 12%.&nbsp;</p><p><blockquote>制药股盘前交易下跌<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">现代</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">收入</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">即将到来的</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">在</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">远的</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">短的</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">的</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">估计数</a>.Moderna、Novavax 和 BioNTech SE 暴跌 4% 至 12%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/22f1d581ec70d04f19c34a0c5a907d67\" tg-width=\"408\" tg-height=\"302\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pharmaceutical stocks dropped in premarket trading<blockquote>制药股在盘前交易中下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPharmaceutical stocks dropped in premarket trading<blockquote>制药股在盘前交易中下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-04 19:20</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Pharmaceutical stocks dropped in premarket trading&nbsp;after&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">Moderna</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">earnings</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">coming</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">in</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">far</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">short</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">of</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">estimates</a>.Moderna,Novavax&nbsp;and&nbsp;BioNTech SE&nbsp;Dived&nbsp;between 4% and 12%.&nbsp;</p><p><blockquote>制药股盘前交易下跌<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">现代</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">收入</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">即将到来的</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">在</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">远的</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">短的</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">的</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">估计数</a>.Moderna、Novavax 和 BioNTech SE 暴跌 4% 至 12%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/22f1d581ec70d04f19c34a0c5a907d67\" tg-width=\"408\" tg-height=\"302\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","NVAX":"诺瓦瓦克斯医药","MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114412462","content_text":"Pharmaceutical stocks dropped in premarket trading after Moderna earnings coming in far short of estimates.Moderna,Novavax and BioNTech SE Dived between 4% and 12%.","news_type":1,"symbols_score_info":{"BNTX":0.9,"MRNA":0.9,"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":3755,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840946057,"gmtCreate":1635580088005,"gmtModify":1635580088005,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579827147050987","idStr":"3579827147050987"},"themes":[],"title":"","htmlText":"Niiice","listText":"Niiice","text":"Niiice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/840946057","repostId":"850756569","repostType":1,"repost":{"id":850756569,"gmtCreate":1634631211448,"gmtModify":1635853120757,"author":{"id":"36984908995200","authorId":"36984908995200","name":"小虎活动","avatar":"https://static.tigerbbs.com/9e396d03155923b283948d2dec9191f8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"36984908995200","idStr":"36984908995200"},"themes":[],"title":"[Halloween Game] Trade or Treat!","htmlText":"Hello, dear Tigers!&nbsp; Happy&nbsp;Halloween!&nbsp;🎃🎃🎃&nbsp;&nbsp; <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap&nbsp;here&nbsp;to&nbsp;play the Halloween game,&nbsp;and&nbsp;you&nbsp;stand&nbsp;a&nbsp;chance&nbsp;to win various rewards!&nbsp;</a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1.&nbsp;How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'.&nbsp; 2.&nbsp;How to collect points? Each player has 30 seconds to catch falling candies while av","listText":"Hello, dear Tigers!&nbsp; Happy&nbsp;Halloween!&nbsp;🎃🎃🎃&nbsp;&nbsp; <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap&nbsp;here&nbsp;to&nbsp;play the Halloween game,&nbsp;and&nbsp;you&nbsp;stand&nbsp;a&nbsp;chance&nbsp;to win various rewards!&nbsp;</a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1.&nbsp;How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'.&nbsp; 2.&nbsp;How to collect points? Each player has 30 seconds to catch falling candies while av","text":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 Tap here to play the Halloween game, and you stand a chance to win various rewards! Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","images":[],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/850756569","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":3463,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840084280,"gmtCreate":1635568727401,"gmtModify":1635568743175,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579827147050987","idStr":"3579827147050987"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/A35.SI\">$ABF SG BOND ETF(A35.SI)$</a>sg is garbage","listText":"<a href=\"https://laohu8.com/S/A35.SI\">$ABF SG BOND ETF(A35.SI)$</a>sg is garbage","text":"$ABF SG BOND ETF(A35.SI)$sg is garbage","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/840084280","isVote":1,"tweetType":1,"viewCount":3411,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855596967,"gmtCreate":1635381615759,"gmtModify":1635381615823,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579827147050987","idStr":"3579827147050987"},"themes":[],"title":"","htmlText":"Seriously last night insider pump and dump?&nbsp;<a href=\"https://laohu8.com/S/ASTS\">$AST SpaceMobile, Inc.(ASTS)$</a>","listText":"Seriously last night insider pump and dump?&nbsp;<a href=\"https://laohu8.com/S/ASTS\">$AST SpaceMobile, Inc.(ASTS)$</a>","text":"Seriously last night insider pump and dump? $AST SpaceMobile, Inc.(ASTS)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855596967","isVote":1,"tweetType":1,"viewCount":3209,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":853129068,"gmtCreate":1634781048703,"gmtModify":1634781051103,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579827147050987","idStr":"3579827147050987"},"themes":[],"title":"","htmlText":"Like near you","listText":"Like near you","text":"Like near you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/853129068","repostId":"1181020907","repostType":4,"repost":{"id":"1181020907","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1634769732,"share":"https://www.laohunote.com/m/news/1181020907?lang=zh_CN&edition=full","pubTime":"2021-10-21 06:42","market":"us","language":"en","title":"Tesla beats Q3 revenue estimates but supply-chain problems impacting factories<blockquote>特斯拉第三季度收入超出预期，但供应链问题影响工厂</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1181020907","media":"Tiger Newspress","summary":"Tesla Inc on Wednesday beat Wall Street expectations for third-quarter revenue on the back of record deliveries as the electric car maker navigated through a prolonged global shortage of chips and raw materials.Tesla said it aims to increase production in the fourth quarter from the previous quarter, adding that \"the magnitude of growth will be determined largely by outside factors.\". Tesla, the world's most valuable automaker, has weathered the pandemic and the global supply-chain crisis better","content":"<p>Tesla Inc&nbsp;on Wednesday beat Wall Street expectations for third-quarter revenue on the back of record deliveries as the electric car maker navigated through a prolonged global shortage of chips and raw materials.</p><p><blockquote>电动汽车制造商特斯拉周三的第三季度收入超出了华尔街的预期，交付量创纪录，因为这家电动汽车制造商克服了全球芯片和原材料长期短缺的问题。</blockquote></p><p> Tesla said it aims to increase production in the fourth quarter from the previous quarter, adding that \"the magnitude of growth will be determined largely by outside factors.\"</p><p><blockquote>特斯拉表示，其目标是在第四季度比上一季度增加产量，并补充说“增长的幅度将在很大程度上取决于外部因素。”</blockquote></p><p> \"A variety of challenges, including semiconductor shortages, congestion at ports and rolling blackouts, have been impacting our ability to keep factories running at full speed,\" the company said.</p><p><blockquote>该公司表示：“包括半导体短缺、港口拥堵和轮流停电在内的各种挑战一直在影响我们保持工厂全速运行的能力。”</blockquote></p><p> Tesla, the world's most valuable automaker, has weathered the pandemic and the global supply-chain crisis better than rivals, posting record revenue for the fifth consecutive quarter in the July to September period, fueled by a production ramp-up at its Chinese factory.</p><p><blockquote>全球最有价值的汽车制造商特斯拉比竞争对手更好地抵御了疫情和全球供应链危机，在中国工厂产量增加的推动下，7 月至 9 月期间连续第五个季度实现创纪录的收入。</blockquote></p><p> Led by billionaire Elon Musk, Tesla faces challenges of maintaining its growth in the face of a prolonged chip shortage, with its factories starting production in Berlin and Texas this year.</p><p><blockquote>在亿万富翁埃隆·马斯克的领导下，面对长期的芯片短缺，特斯拉面临着维持增长的挑战，其在柏林和德克萨斯的工厂今年开始生产。</blockquote></p><p> Tesla shares, up about 23% this year, were down about 1.6% in extended trade late on Wednesday.</p><p><blockquote>特斯拉股价今年上涨约 23%，但在周三晚间的盘后交易中下跌约 1.6%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d998d6369e593952a4c3d57b9224c4a6\" tg-width=\"848\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Revenue rose to $13.76 billion from $8.77 billion a year earlier. Analysts had expected revenue of about $13.63 billion, according to IBES data from Refinitiv.</p><p><blockquote>收入从去年同期的 87.7 亿美元增至 137.6 亿美元。根据 Refinitiv 的 IBES 数据，分析师此前预计收入约为 136.3 亿美元。</blockquote></p><p> Tesla's automotive gross margin, excluding environmental credits, rose to 28.8%, from 25.8% the previous quarter.</p><p><blockquote>特斯拉不包括环境信用的汽车毛利率从上一季度的 25.8% 上升至 28.8%。</blockquote></p><p> Tesla has been raising prices in the United States, which helped cushion the impact of the supply-chain costs, analysts said.</p><p><blockquote>分析师表示，特斯拉一直在提高美国的价格，这有助于缓冲供应链成本的影响。</blockquote></p><p> \"Tesla's average selling price (ASP) of vehicles were higher than expected and the U.S. market drove that,\" said Gene Munster, managing partner at venture capital firm Loup Ventures, an investor in Tesla. Tesla said its ongoing cost-cutting efforts helped counter the declines in its ASPs stemming from sales of lower-priced vehicles like the Model 3 and Model Y.</p><p><blockquote>特斯拉投资者风险投资公司 Loup Ventures 的执行合伙人吉恩·蒙斯特 (Gene Munster) 表示：“特斯拉的汽车平均售价 (ASP) 高于预期，而美国市场推动了这一趋势。”特斯拉表示，其持续的成本削减努力有助于抵消 Model 3 和 Model Y 等低价汽车销售导致的平均售价下降。</blockquote></p><p> Tesla has cut costs with the use of more Chinese parts including batteries. The company posted robust sales in China, where its Shanghai factory has surpassed the Tesla factory in Fremont, California, in terms of production.</p><p><blockquote>特斯拉通过使用包括电池在内的更多中国零部件来削减成本。该公司在中国的销售强劲，其上海工厂的产量已经超过了位于加州弗里蒙特的特斯拉工厂。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/bdf4574208dc79952acb2a1ca49c22b2\" tg-width=\"960\" tg-height=\"582\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla beats Q3 revenue estimates but supply-chain problems impacting factories<blockquote>特斯拉第三季度收入超出预期，但供应链问题影响工厂</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla beats Q3 revenue estimates but supply-chain problems impacting factories<blockquote>特斯拉第三季度收入超出预期，但供应链问题影响工厂</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-10-21 06:42</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Tesla Inc&nbsp;on Wednesday beat Wall Street expectations for third-quarter revenue on the back of record deliveries as the electric car maker navigated through a prolonged global shortage of chips and raw materials.</p><p><blockquote>电动汽车制造商特斯拉周三的第三季度收入超出了华尔街的预期，交付量创纪录，因为这家电动汽车制造商克服了全球芯片和原材料长期短缺的问题。</blockquote></p><p> Tesla said it aims to increase production in the fourth quarter from the previous quarter, adding that \"the magnitude of growth will be determined largely by outside factors.\"</p><p><blockquote>特斯拉表示，其目标是在第四季度比上一季度增加产量，并补充说“增长的幅度将在很大程度上取决于外部因素。”</blockquote></p><p> \"A variety of challenges, including semiconductor shortages, congestion at ports and rolling blackouts, have been impacting our ability to keep factories running at full speed,\" the company said.</p><p><blockquote>该公司表示：“包括半导体短缺、港口拥堵和轮流停电在内的各种挑战一直在影响我们保持工厂全速运行的能力。”</blockquote></p><p> Tesla, the world's most valuable automaker, has weathered the pandemic and the global supply-chain crisis better than rivals, posting record revenue for the fifth consecutive quarter in the July to September period, fueled by a production ramp-up at its Chinese factory.</p><p><blockquote>全球最有价值的汽车制造商特斯拉比竞争对手更好地抵御了疫情和全球供应链危机，在中国工厂产量增加的推动下，7 月至 9 月期间连续第五个季度实现创纪录的收入。</blockquote></p><p> Led by billionaire Elon Musk, Tesla faces challenges of maintaining its growth in the face of a prolonged chip shortage, with its factories starting production in Berlin and Texas this year.</p><p><blockquote>在亿万富翁埃隆·马斯克的领导下，面对长期的芯片短缺，特斯拉面临着维持增长的挑战，其在柏林和德克萨斯的工厂今年开始生产。</blockquote></p><p> Tesla shares, up about 23% this year, were down about 1.6% in extended trade late on Wednesday.</p><p><blockquote>特斯拉股价今年上涨约 23%，但在周三晚间的盘后交易中下跌约 1.6%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d998d6369e593952a4c3d57b9224c4a6\" tg-width=\"848\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Revenue rose to $13.76 billion from $8.77 billion a year earlier. Analysts had expected revenue of about $13.63 billion, according to IBES data from Refinitiv.</p><p><blockquote>收入从去年同期的 87.7 亿美元增至 137.6 亿美元。根据 Refinitiv 的 IBES 数据，分析师此前预计收入约为 136.3 亿美元。</blockquote></p><p> Tesla's automotive gross margin, excluding environmental credits, rose to 28.8%, from 25.8% the previous quarter.</p><p><blockquote>特斯拉不包括环境信用的汽车毛利率从上一季度的 25.8% 上升至 28.8%。</blockquote></p><p> Tesla has been raising prices in the United States, which helped cushion the impact of the supply-chain costs, analysts said.</p><p><blockquote>分析师表示，特斯拉一直在提高美国的价格，这有助于缓冲供应链成本的影响。</blockquote></p><p> \"Tesla's average selling price (ASP) of vehicles were higher than expected and the U.S. market drove that,\" said Gene Munster, managing partner at venture capital firm Loup Ventures, an investor in Tesla. Tesla said its ongoing cost-cutting efforts helped counter the declines in its ASPs stemming from sales of lower-priced vehicles like the Model 3 and Model Y.</p><p><blockquote>特斯拉投资者风险投资公司 Loup Ventures 的执行合伙人吉恩·蒙斯特 (Gene Munster) 表示：“特斯拉的汽车平均售价 (ASP) 高于预期，而美国市场推动了这一趋势。”特斯拉表示，其持续的成本削减努力有助于抵消 Model 3 和 Model Y 等低价汽车销售导致的平均售价下降。</blockquote></p><p> Tesla has cut costs with the use of more Chinese parts including batteries. The company posted robust sales in China, where its Shanghai factory has surpassed the Tesla factory in Fremont, California, in terms of production.</p><p><blockquote>特斯拉通过使用包括电池在内的更多中国零部件来削减成本。该公司在中国的销售强劲，其上海工厂的产量已经超过了位于加州弗里蒙特的特斯拉工厂。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/bdf4574208dc79952acb2a1ca49c22b2\" tg-width=\"960\" tg-height=\"582\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1181020907","content_text":"Tesla Inc on Wednesday beat Wall Street expectations for third-quarter revenue on the back of record deliveries as the electric car maker navigated through a prolonged global shortage of chips and raw materials.\nTesla said it aims to increase production in the fourth quarter from the previous quarter, adding that \"the magnitude of growth will be determined largely by outside factors.\"\n\"A variety of challenges, including semiconductor shortages, congestion at ports and rolling blackouts, have been impacting our ability to keep factories running at full speed,\" the company said.\nTesla, the world's most valuable automaker, has weathered the pandemic and the global supply-chain crisis better than rivals, posting record revenue for the fifth consecutive quarter in the July to September period, fueled by a production ramp-up at its Chinese factory.\nLed by billionaire Elon Musk, Tesla faces challenges of maintaining its growth in the face of a prolonged chip shortage, with its factories starting production in Berlin and Texas this year.\nTesla shares, up about 23% this year, were down about 1.6% in extended trade late on Wednesday.\n\nRevenue rose to $13.76 billion from $8.77 billion a year earlier. Analysts had expected revenue of about $13.63 billion, according to IBES data from Refinitiv.\nTesla's automotive gross margin, excluding environmental credits, rose to 28.8%, from 25.8% the previous quarter.\nTesla has been raising prices in the United States, which helped cushion the impact of the supply-chain costs, analysts said.\n\"Tesla's average selling price (ASP) of vehicles were higher than expected and the U.S. market drove that,\" said Gene Munster, managing partner at venture capital firm Loup Ventures, an investor in Tesla. Tesla said its ongoing cost-cutting efforts helped counter the declines in its ASPs stemming from sales of lower-priced vehicles like the Model 3 and Model Y.\nTesla has cut costs with the use of more Chinese parts including batteries. The company posted robust sales in China, where its Shanghai factory has surpassed the Tesla factory in Fremont, California, in terms of production.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":3071,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":864653997,"gmtCreate":1633099274018,"gmtModify":1633099274187,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579827147050987","idStr":"3579827147050987"},"themes":[],"title":"","htmlText":"Rather great news. First aim is to tahan the rest of this year in SG without getting jabbed.","listText":"Rather great news. First aim is to tahan the rest of this year in SG without getting jabbed.","text":"Rather great news. First aim is to tahan the rest of this year in SG without getting jabbed.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864653997","repostId":"2172968435","repostType":4,"isVote":1,"tweetType":1,"viewCount":3170,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":861696598,"gmtCreate":1632490537414,"gmtModify":1632717966740,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579827147050987","idStr":"3579827147050987"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/ES3.SI\">$STI ETF(ES3.SI)$</a>bloodshed","listText":"<a href=\"https://laohu8.com/S/ES3.SI\">$STI ETF(ES3.SI)$</a>bloodshed","text":"$STI ETF(ES3.SI)$bloodshed","images":[{"img":"https://static.tigerbbs.com/ce8180f7add6d5d3a728b0731b072ed7","width":"1440","height":"2560"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/861696598","isVote":1,"tweetType":1,"viewCount":932,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":817778887,"gmtCreate":1630993766649,"gmtModify":1631889031411,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579827147050987","idStr":"3579827147050987"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/VTI\">$Vanguard Total Stock Market Index Fund ETF Shares(VTI)$</a>fundamentals","listText":"<a href=\"https://laohu8.com/S/VTI\">$Vanguard Total Stock Market Index Fund ETF Shares(VTI)$</a>fundamentals","text":"$Vanguard Total Stock Market Index Fund ETF Shares(VTI)$fundamentals","images":[{"img":"https://static.tigerbbs.com/645563ba6226827b087b3372854573db","width":"1440","height":"4213"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/817778887","isVote":1,"tweetType":1,"viewCount":668,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":815377291,"gmtCreate":1630651476413,"gmtModify":1631888839845,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579827147050987","idStr":"3579827147050987"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/EHG.SI\">$Econ Healthcare(EHG.SI)$</a>ridiculous.............","listText":"<a href=\"https://laohu8.com/S/EHG.SI\">$Econ Healthcare(EHG.SI)$</a>ridiculous.............","text":"$Econ Healthcare(EHG.SI)$ridiculous.............","images":[{"img":"https://static.tigerbbs.com/5e170e0f85cdfb5cffb4dcd966b09690","width":"1440","height":"2560"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/815377291","isVote":1,"tweetType":1,"viewCount":1251,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":801473651,"gmtCreate":1627531188973,"gmtModify":1631888757157,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579827147050987","idStr":"3579827147050987"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/VIOT\">$Viomi Technology Co.(VIOT)$</a>it's a big rip","listText":"<a href=\"https://laohu8.com/S/VIOT\">$Viomi Technology Co.(VIOT)$</a>it's a big rip","text":"$Viomi Technology Co.(VIOT)$it's a big rip","images":[{"img":"https://static.tigerbbs.com/9f72ea5a81dccc607e4e2ea80495db68","width":"1440","height":"2560"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/801473651","isVote":1,"tweetType":1,"viewCount":940,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":149288629,"gmtCreate":1625730338261,"gmtModify":1633937933801,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579827147050987","idStr":"3579827147050987"},"themes":[],"title":"","htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/149288629","repostId":"2143978458","repostType":2,"isVote":1,"tweetType":1,"viewCount":699,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":140901445,"gmtCreate":1625621844487,"gmtModify":1631888847212,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579827147050987","idStr":"3579827147050987"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/ASTS\">$AST SpaceMobile, Inc.(ASTS)$</a>investing in the future&nbsp;","listText":"<a href=\"https://laohu8.com/S/ASTS\">$AST SpaceMobile, Inc.(ASTS)$</a>investing in the future&nbsp;","text":"$AST SpaceMobile, Inc.(ASTS)$investing in the future","images":[{"img":"https://static.tigerbbs.com/2eb29b563eea1c131f8d29e53d58ed9b","width":"1440","height":"2560"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/140901445","isVote":1,"tweetType":1,"viewCount":753,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":168947412,"gmtCreate":1623948160336,"gmtModify":1631888757188,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579827147050987","idStr":"3579827147050987"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/VIOT\">$Viomi Technology Co.(VIOT)$</a>good vibes","listText":"<a href=\"https://laohu8.com/S/VIOT\">$Viomi Technology Co.(VIOT)$</a>good vibes","text":"$Viomi Technology Co.(VIOT)$good vibes","images":[{"img":"https://static.tigerbbs.com/10750afe5f6d8e87ca0eae185899c095","width":"1440","height":"2560"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/168947412","isVote":1,"tweetType":1,"viewCount":1114,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":160783621,"gmtCreate":1623806611663,"gmtModify":1631889279304,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579827147050987","idStr":"3579827147050987"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/06699\">$Angelalign Technology Inc.(06699)$</a>wow hmm","listText":"<a href=\"https://laohu8.com/S/06699\">$Angelalign Technology Inc.(06699)$</a>wow hmm","text":"$Angelalign Technology Inc.(06699)$wow hmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/160783621","isVote":1,"tweetType":1,"viewCount":746,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":188007101,"gmtCreate":1623414924803,"gmtModify":1634033551654,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579827147050987","idStr":"3579827147050987"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>appreciate a free like :)","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>appreciate a free like :)","text":"$AMC Entertainment(AMC)$appreciate a free like :)","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":19,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/188007101","isVote":1,"tweetType":1,"viewCount":1489,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183070016,"gmtCreate":1623296887635,"gmtModify":1631888757199,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579827147050987","idStr":"3579827147050987"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/VIOT\">$Viomi Technology Co.(VIOT)$</a>rip the recent gains.. wwe're going back down","listText":"<a href=\"https://laohu8.com/S/VIOT\">$Viomi Technology Co.(VIOT)$</a>rip the recent gains.. wwe're going back down","text":"$Viomi Technology Co.(VIOT)$rip the recent gains.. wwe're going back down","images":[{"img":"https://static.tigerbbs.com/cffac8eb8ed4bff69988051e4dd4e71e","width":"1440","height":"2560"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/183070016","isVote":1,"tweetType":1,"viewCount":730,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"hots":[{"id":188007101,"gmtCreate":1623414924803,"gmtModify":1634033551654,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579827147050987","authorIdStr":"3579827147050987"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>appreciate a free like :)","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>appreciate a free like :)","text":"$AMC Entertainment(AMC)$appreciate a free like :)","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":19,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/188007101","isVote":1,"tweetType":1,"viewCount":1489,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":844019974,"gmtCreate":1636376601266,"gmtModify":1636376649125,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579827147050987","authorIdStr":"3579827147050987"},"themes":[],"title":"","htmlText":"Last November?! Where was this in mainstream media all this time?!&nbsp;","listText":"Last November?! Where was this in mainstream media all this time?!&nbsp;","text":"Last November?! Where was this in mainstream media all this time?!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844019974","repostId":"1141245956","repostType":2,"repost":{"id":"1141245956","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636375961,"share":"https://www.laohunote.com/m/news/1141245956?lang=zh_CN&edition=full","pubTime":"2021-11-08 20:52","market":"us","language":"en","title":"Regeneron shares rose 2.2% in premarket trading<blockquote>再生元股价在盘前交易中上涨 2.2%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1141245956","media":"Tiger Newspress","summary":"Regeneron shares rose 2.2% in premarket trading.\nRegeneron Pharmaceuticals Inc said on Monday a sing","content":"<p>Regeneron&nbsp;shares&nbsp;rose&nbsp;2.2%&nbsp;in&nbsp;premarket&nbsp;trading.</p><p><blockquote>再生元股价在盘前交易中上涨 2.2%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1d06980fde1a0bd99affdab9ee4beb4b\" tg-width=\"889\" tg-height=\"603\" width=\"100%\" height=\"auto\">Regeneron Pharmaceuticals Inc said on Monday a single dose of its antibody cocktail reduced the risk of contracting COVID-19 by 81.6% in the two to eight months period following the drug's administration in a late-stage trial.</p><p><blockquote>再生元制药公司周一表示，在后期试验中使用该药物后的两到八个月内，单剂量其抗体鸡尾酒可将感染 COVID-19 的风险降低 81.6%。</blockquote></p><p> The results showed that antibody therapy, REGEN-COV, has the potential to provide long-lasting immunity from COVID-19 infection, said Myron Cohen, who leads monoclonal antibody efforts for the U.S. National Institutes of Health-sponsored COVID Prevention Network.</p><p><blockquote>美国国立卫生研究院赞助的COVID预防网络单克隆抗体工作负责人迈伦·科恩说，结果表明，抗体疗法REGEN-COV有可能提供对新冠肺炎感染的持久免疫力。</blockquote></p><p> Such immunity is particularly important for immunocompromised people and those not responding to vaccines, the company said.</p><p><blockquote>该公司表示，这种免疫力对于免疫功能低下的人和对疫苗没有反应的人尤其重要。</blockquote></p><p> The therapy had previously shown&nbsp;an 81.4% risk reduction during the first month after administration.</p><p><blockquote>该疗法之前在给药后的第一个月内显示风险降低了81.4%。</blockquote></p><p> During the 8-month assessment period, there were no hospitalizations for COVID-19 in the REGEN-COV group, but in the placebo group 6 such incidents were recorded, Regeneron said.</p><p><blockquote>Regeneron 表示，在 8 个月的评估期内，REGEN-COV 组中没有因 COVID-19 住院的病例，但安慰剂组中记录了 6 起此类事件。</blockquote></p><p> The U.S. health regulator in July expanded REGEN-COV's authorization to enable its use as a preventive treatment in people exposed to infected individuals, and those at high risk of such exposure in settings such as nursing homes or prisons.</p><p><blockquote>美国卫生监管机构在7月份扩大了REGEN-COV的授权，使其能够用作接触感染者的人以及在疗养院或监狱等环境中接触感染者的高风险人群的预防性治疗。</blockquote></p><p> It was authorized in the United States last November to treat people with mild-to-moderate COVID-19 disease.</p><p><blockquote>去年11月，它在美国被授权用于治疗轻度至中度新冠肺炎疾病患者。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regeneron shares rose 2.2% in premarket trading<blockquote>再生元股价在盘前交易中上涨 2.2%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegeneron shares rose 2.2% in premarket trading<blockquote>再生元股价在盘前交易中上涨 2.2%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-08 20:52</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Regeneron&nbsp;shares&nbsp;rose&nbsp;2.2%&nbsp;in&nbsp;premarket&nbsp;trading.</p><p><blockquote>再生元股价在盘前交易中上涨 2.2%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1d06980fde1a0bd99affdab9ee4beb4b\" tg-width=\"889\" tg-height=\"603\" width=\"100%\" height=\"auto\">Regeneron Pharmaceuticals Inc said on Monday a single dose of its antibody cocktail reduced the risk of contracting COVID-19 by 81.6% in the two to eight months period following the drug's administration in a late-stage trial.</p><p><blockquote>再生元制药公司周一表示，在后期试验中使用该药物后的两到八个月内，单剂量其抗体鸡尾酒可将感染 COVID-19 的风险降低 81.6%。</blockquote></p><p> The results showed that antibody therapy, REGEN-COV, has the potential to provide long-lasting immunity from COVID-19 infection, said Myron Cohen, who leads monoclonal antibody efforts for the U.S. National Institutes of Health-sponsored COVID Prevention Network.</p><p><blockquote>美国国立卫生研究院赞助的COVID预防网络单克隆抗体工作负责人迈伦·科恩说，结果表明，抗体疗法REGEN-COV有可能提供对新冠肺炎感染的持久免疫力。</blockquote></p><p> Such immunity is particularly important for immunocompromised people and those not responding to vaccines, the company said.</p><p><blockquote>该公司表示，这种免疫力对于免疫功能低下的人和对疫苗没有反应的人尤其重要。</blockquote></p><p> The therapy had previously shown&nbsp;an 81.4% risk reduction during the first month after administration.</p><p><blockquote>该疗法之前在给药后的第一个月内显示风险降低了81.4%。</blockquote></p><p> During the 8-month assessment period, there were no hospitalizations for COVID-19 in the REGEN-COV group, but in the placebo group 6 such incidents were recorded, Regeneron said.</p><p><blockquote>Regeneron 表示，在 8 个月的评估期内，REGEN-COV 组中没有因 COVID-19 住院的病例，但安慰剂组中记录了 6 起此类事件。</blockquote></p><p> The U.S. health regulator in July expanded REGEN-COV's authorization to enable its use as a preventive treatment in people exposed to infected individuals, and those at high risk of such exposure in settings such as nursing homes or prisons.</p><p><blockquote>美国卫生监管机构在7月份扩大了REGEN-COV的授权，使其能够用作接触感染者的人以及在疗养院或监狱等环境中接触感染者的高风险人群的预防性治疗。</blockquote></p><p> It was authorized in the United States last November to treat people with mild-to-moderate COVID-19 disease.</p><p><blockquote>去年11月，它在美国被授权用于治疗轻度至中度新冠肺炎疾病患者。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"REGN":"再生元制药公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1141245956","content_text":"Regeneron shares rose 2.2% in premarket trading.\nRegeneron Pharmaceuticals Inc said on Monday a single dose of its antibody cocktail reduced the risk of contracting COVID-19 by 81.6% in the two to eight months period following the drug's administration in a late-stage trial.\nThe results showed that antibody therapy, REGEN-COV, has the potential to provide long-lasting immunity from COVID-19 infection, said Myron Cohen, who leads monoclonal antibody efforts for the U.S. National Institutes of Health-sponsored COVID Prevention Network.\nSuch immunity is particularly important for immunocompromised people and those not responding to vaccines, the company said.\nThe therapy had previously shown an 81.4% risk reduction during the first month after administration.\nDuring the 8-month assessment period, there were no hospitalizations for COVID-19 in the REGEN-COV group, but in the placebo group 6 such incidents were recorded, Regeneron said.\nThe U.S. health regulator in July expanded REGEN-COV's authorization to enable its use as a preventive treatment in people exposed to infected individuals, and those at high risk of such exposure in settings such as nursing homes or prisons.\nIt was authorized in the United States last November to treat people with mild-to-moderate COVID-19 disease.","news_type":1,"symbols_score_info":{"REGN":0.9}},"isVote":1,"tweetType":1,"viewCount":4862,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606014353,"gmtCreate":1638801265327,"gmtModify":1638801265468,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579827147050987","authorIdStr":"3579827147050987"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/META\">$Roundhill Ball Metaverse ETF(META)$</a>Don't panic amongst commoner fears. Buy the dip.","listText":"<a href=\"https://laohu8.com/S/META\">$Roundhill Ball Metaverse ETF(META)$</a>Don't panic amongst commoner fears. Buy the dip.","text":"$Roundhill Ball Metaverse ETF(META)$Don't panic amongst commoner fears. Buy the dip.","images":[{"img":"https://static.tigerbbs.com/b0e398f47591254152b057b8cb9f72fa","width":"1440","height":"2560"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606014353","isVote":1,"tweetType":1,"viewCount":3642,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":104694641,"gmtCreate":1620382122583,"gmtModify":1631889131093,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579827147050987","authorIdStr":"3579827147050987"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/D8DU.SI\">$FIRST SHIP LEASE TRUST(D8DU.SI)$</a>[流泪]&nbsp;","listText":"<a href=\"https://laohu8.com/S/D8DU.SI\">$FIRST SHIP LEASE TRUST(D8DU.SI)$</a>[流泪]&nbsp;","text":"$FIRST SHIP LEASE TRUST(D8DU.SI)$[流泪]","images":[{"img":"https://static.tigerbbs.com/6efc4b6dfecf2867683b81dd725c1069","width":"1440","height":"2560"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/104694641","isVote":1,"tweetType":1,"viewCount":982,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":608798676,"gmtCreate":1638787262028,"gmtModify":1638787262432,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579827147050987","authorIdStr":"3579827147050987"},"themes":[],"title":"","htmlText":"Speculation play...","listText":"Speculation play...","text":"Speculation play...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608798676","repostId":"1191547402","repostType":2,"repost":{"id":"1191547402","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638783371,"share":"https://www.laohunote.com/m/news/1191547402?lang=zh_CN&edition=full","pubTime":"2021-12-06 17:36","market":"us","language":"en","title":"CF Acquisition Corp VI stock jumped 31% in premarket trading<blockquote>CF Acquisition Corp VI 股票在盘前交易中上涨 31%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1191547402","media":"Tiger Newspress","summary":"CF Acquisition Corp VI stock jumped 31% in premarket trading as YouTube competitor Rumble would go p","content":"<p>CF Acquisition Corp VI stock jumped 31% in premarket trading&nbsp;as&nbsp;YouTube competitor Rumble&nbsp;would&nbsp;go public via SPAC CF Acquisition VI.</p><p><blockquote>由于 YouTube 竞争对手 Rumble 将通过 SPAC CF Acquisition VI 上市，CF Acquisition Corp VI 股价在盘前交易中上涨 31%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/b8dc893dd9a925f906f6e5709286bb79\" tg-width=\"850\" tg-height=\"620\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Canadian video platform Rumble Inc said&nbsp;it would go public by merging with blank-check firm&nbsp;CF Acquisition Corp VI&nbsp;at an initial enterprise value of $2.1 billion.</p><p><blockquote>加拿大视频平台 Rumble Inc 表示，将通过与空白支票公司 CF Acquisition Corp VI 合并上市，初始企业价值为 21 亿美元。</blockquote></p><p> The deal is expected to provide about $400 million in proceeds to Rumble, the company said in a statement.</p><p><blockquote>该公司在一份声明中表示，这笔交易预计将为 Rumble 提供约 4 亿美元的收益。</blockquote></p><p> Upon the deal's closing, Rumble said founder and Chief Executive Officer Chris Pavlovski will retain voting control.</p><p><blockquote>交易完成后，Rumble 表示创始人兼首席执行官克里斯·帕夫洛夫斯基 (Chris Pavlovski) 将保留投票控制权。</blockquote></p><p> The combined company will be called Rumble and is expected to list on the Nasdaq.</p><p><blockquote>合并后的公司将被命名为Rumble，预计将在纳斯达克上市。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CF Acquisition Corp VI stock jumped 31% in premarket trading<blockquote>CF Acquisition Corp VI 股票在盘前交易中上涨 31%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCF Acquisition Corp VI stock jumped 31% in premarket trading<blockquote>CF Acquisition Corp VI 股票在盘前交易中上涨 31%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-06 17:36</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>CF Acquisition Corp VI stock jumped 31% in premarket trading&nbsp;as&nbsp;YouTube competitor Rumble&nbsp;would&nbsp;go public via SPAC CF Acquisition VI.</p><p><blockquote>由于 YouTube 竞争对手 Rumble 将通过 SPAC CF Acquisition VI 上市，CF Acquisition Corp VI 股价在盘前交易中上涨 31%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/b8dc893dd9a925f906f6e5709286bb79\" tg-width=\"850\" tg-height=\"620\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Canadian video platform Rumble Inc said&nbsp;it would go public by merging with blank-check firm&nbsp;CF Acquisition Corp VI&nbsp;at an initial enterprise value of $2.1 billion.</p><p><blockquote>加拿大视频平台 Rumble Inc 表示，将通过与空白支票公司 CF Acquisition Corp VI 合并上市，初始企业价值为 21 亿美元。</blockquote></p><p> The deal is expected to provide about $400 million in proceeds to Rumble, the company said in a statement.</p><p><blockquote>该公司在一份声明中表示，这笔交易预计将为 Rumble 提供约 4 亿美元的收益。</blockquote></p><p> Upon the deal's closing, Rumble said founder and Chief Executive Officer Chris Pavlovski will retain voting control.</p><p><blockquote>交易完成后，Rumble 表示创始人兼首席执行官克里斯·帕夫洛夫斯基 (Chris Pavlovski) 将保留投票控制权。</blockquote></p><p> The combined company will be called Rumble and is expected to list on the Nasdaq.</p><p><blockquote>合并后的公司将被命名为Rumble，预计将在纳斯达克上市。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191547402","content_text":"CF Acquisition Corp VI stock jumped 31% in premarket trading as YouTube competitor Rumble would go public via SPAC CF Acquisition VI.\n\nCanadian video platform Rumble Inc said it would go public by merging with blank-check firm CF Acquisition Corp VI at an initial enterprise value of $2.1 billion.\nThe deal is expected to provide about $400 million in proceeds to Rumble, the company said in a statement.\nUpon the deal's closing, Rumble said founder and Chief Executive Officer Chris Pavlovski will retain voting control.\nThe combined company will be called Rumble and is expected to list on the Nasdaq.","news_type":1,"symbols_score_info":{"CFVI":0.9}},"isVote":1,"tweetType":1,"viewCount":3862,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":848709368,"gmtCreate":1636025415150,"gmtModify":1636027785724,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579827147050987","authorIdStr":"3579827147050987"},"themes":[],"title":"","htmlText":"The more truth about this covid situation gets spread out there, the more big corrupt pharmas should dive in the short term.&nbsp;","listText":"The more truth about this covid situation gets spread out there, the more big corrupt pharmas should dive in the short term.&nbsp;","text":"The more truth about this covid situation gets spread out there, the more big corrupt pharmas should dive in the short term.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848709368","repostId":"1114412462","repostType":2,"repost":{"id":"1114412462","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636024828,"share":"https://www.laohunote.com/m/news/1114412462?lang=zh_CN&edition=full","pubTime":"2021-11-04 19:20","market":"us","language":"en","title":"Pharmaceutical stocks dropped in premarket trading<blockquote>制药股在盘前交易中下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1114412462","media":"Tiger Newspress","summary":"Pharmaceutical stocks dropped in premarket trading after Moderna earnings coming in far short of est","content":"<p>Pharmaceutical stocks dropped in premarket trading&nbsp;after&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">Moderna</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">earnings</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">coming</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">in</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">far</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">short</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">of</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">estimates</a>.Moderna,Novavax&nbsp;and&nbsp;BioNTech SE&nbsp;Dived&nbsp;between 4% and 12%.&nbsp;</p><p><blockquote>制药股盘前交易下跌<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">现代</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">收入</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">即将到来的</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">在</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">远的</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">短的</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">的</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">估计数</a>.Moderna、Novavax 和 BioNTech SE 暴跌 4% 至 12%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/22f1d581ec70d04f19c34a0c5a907d67\" tg-width=\"408\" tg-height=\"302\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pharmaceutical stocks dropped in premarket trading<blockquote>制药股在盘前交易中下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPharmaceutical stocks dropped in premarket trading<blockquote>制药股在盘前交易中下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-04 19:20</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Pharmaceutical stocks dropped in premarket trading&nbsp;after&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">Moderna</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">earnings</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">coming</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">in</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">far</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">short</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">of</a>&nbsp;<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">estimates</a>.Moderna,Novavax&nbsp;and&nbsp;BioNTech SE&nbsp;Dived&nbsp;between 4% and 12%.&nbsp;</p><p><blockquote>制药股盘前交易下跌<a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">现代</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">收入</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">即将到来的</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">在</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">远的</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">短的</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">的</a> <a href=\"https://laohu8.com/NW/1101079537\" target=\"_blank\">估计数</a>.Moderna、Novavax 和 BioNTech SE 暴跌 4% 至 12%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/22f1d581ec70d04f19c34a0c5a907d67\" tg-width=\"408\" tg-height=\"302\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","NVAX":"诺瓦瓦克斯医药","MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114412462","content_text":"Pharmaceutical stocks dropped in premarket trading after Moderna earnings coming in far short of estimates.Moderna,Novavax and BioNTech SE Dived between 4% and 12%.","news_type":1,"symbols_score_info":{"BNTX":0.9,"MRNA":0.9,"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":3755,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":864653997,"gmtCreate":1633099274018,"gmtModify":1633099274187,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579827147050987","authorIdStr":"3579827147050987"},"themes":[],"title":"","htmlText":"Rather great news. First aim is to tahan the rest of this year in SG without getting jabbed.","listText":"Rather great news. First aim is to tahan the rest of this year in SG without getting jabbed.","text":"Rather great news. First aim is to tahan the rest of this year in SG without getting jabbed.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864653997","repostId":"2172968435","repostType":4,"isVote":1,"tweetType":1,"viewCount":3170,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":801473651,"gmtCreate":1627531188973,"gmtModify":1631888757157,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579827147050987","authorIdStr":"3579827147050987"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/VIOT\">$Viomi Technology Co.(VIOT)$</a>it's a big rip","listText":"<a href=\"https://laohu8.com/S/VIOT\">$Viomi Technology Co.(VIOT)$</a>it's a big rip","text":"$Viomi Technology Co.(VIOT)$it's a big rip","images":[{"img":"https://static.tigerbbs.com/9f72ea5a81dccc607e4e2ea80495db68","width":"1440","height":"2560"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/801473651","isVote":1,"tweetType":1,"viewCount":940,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":853129068,"gmtCreate":1634781048703,"gmtModify":1634781051103,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579827147050987","authorIdStr":"3579827147050987"},"themes":[],"title":"","htmlText":"Like near you","listText":"Like near you","text":"Like near you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/853129068","repostId":"1181020907","repostType":4,"repost":{"id":"1181020907","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1634769732,"share":"https://www.laohunote.com/m/news/1181020907?lang=zh_CN&edition=full","pubTime":"2021-10-21 06:42","market":"us","language":"en","title":"Tesla beats Q3 revenue estimates but supply-chain problems impacting factories<blockquote>特斯拉第三季度收入超出预期，但供应链问题影响工厂</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1181020907","media":"Tiger Newspress","summary":"Tesla Inc on Wednesday beat Wall Street expectations for third-quarter revenue on the back of record deliveries as the electric car maker navigated through a prolonged global shortage of chips and raw materials.Tesla said it aims to increase production in the fourth quarter from the previous quarter, adding that \"the magnitude of growth will be determined largely by outside factors.\". Tesla, the world's most valuable automaker, has weathered the pandemic and the global supply-chain crisis better","content":"<p>Tesla Inc&nbsp;on Wednesday beat Wall Street expectations for third-quarter revenue on the back of record deliveries as the electric car maker navigated through a prolonged global shortage of chips and raw materials.</p><p><blockquote>电动汽车制造商特斯拉周三的第三季度收入超出了华尔街的预期，交付量创纪录，因为这家电动汽车制造商克服了全球芯片和原材料长期短缺的问题。</blockquote></p><p> Tesla said it aims to increase production in the fourth quarter from the previous quarter, adding that \"the magnitude of growth will be determined largely by outside factors.\"</p><p><blockquote>特斯拉表示，其目标是在第四季度比上一季度增加产量，并补充说“增长的幅度将在很大程度上取决于外部因素。”</blockquote></p><p> \"A variety of challenges, including semiconductor shortages, congestion at ports and rolling blackouts, have been impacting our ability to keep factories running at full speed,\" the company said.</p><p><blockquote>该公司表示：“包括半导体短缺、港口拥堵和轮流停电在内的各种挑战一直在影响我们保持工厂全速运行的能力。”</blockquote></p><p> Tesla, the world's most valuable automaker, has weathered the pandemic and the global supply-chain crisis better than rivals, posting record revenue for the fifth consecutive quarter in the July to September period, fueled by a production ramp-up at its Chinese factory.</p><p><blockquote>全球最有价值的汽车制造商特斯拉比竞争对手更好地抵御了疫情和全球供应链危机，在中国工厂产量增加的推动下，7 月至 9 月期间连续第五个季度实现创纪录的收入。</blockquote></p><p> Led by billionaire Elon Musk, Tesla faces challenges of maintaining its growth in the face of a prolonged chip shortage, with its factories starting production in Berlin and Texas this year.</p><p><blockquote>在亿万富翁埃隆·马斯克的领导下，面对长期的芯片短缺，特斯拉面临着维持增长的挑战，其在柏林和德克萨斯的工厂今年开始生产。</blockquote></p><p> Tesla shares, up about 23% this year, were down about 1.6% in extended trade late on Wednesday.</p><p><blockquote>特斯拉股价今年上涨约 23%，但在周三晚间的盘后交易中下跌约 1.6%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d998d6369e593952a4c3d57b9224c4a6\" tg-width=\"848\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Revenue rose to $13.76 billion from $8.77 billion a year earlier. Analysts had expected revenue of about $13.63 billion, according to IBES data from Refinitiv.</p><p><blockquote>收入从去年同期的 87.7 亿美元增至 137.6 亿美元。根据 Refinitiv 的 IBES 数据，分析师此前预计收入约为 136.3 亿美元。</blockquote></p><p> Tesla's automotive gross margin, excluding environmental credits, rose to 28.8%, from 25.8% the previous quarter.</p><p><blockquote>特斯拉不包括环境信用的汽车毛利率从上一季度的 25.8% 上升至 28.8%。</blockquote></p><p> Tesla has been raising prices in the United States, which helped cushion the impact of the supply-chain costs, analysts said.</p><p><blockquote>分析师表示，特斯拉一直在提高美国的价格，这有助于缓冲供应链成本的影响。</blockquote></p><p> \"Tesla's average selling price (ASP) of vehicles were higher than expected and the U.S. market drove that,\" said Gene Munster, managing partner at venture capital firm Loup Ventures, an investor in Tesla. Tesla said its ongoing cost-cutting efforts helped counter the declines in its ASPs stemming from sales of lower-priced vehicles like the Model 3 and Model Y.</p><p><blockquote>特斯拉投资者风险投资公司 Loup Ventures 的执行合伙人吉恩·蒙斯特 (Gene Munster) 表示：“特斯拉的汽车平均售价 (ASP) 高于预期，而美国市场推动了这一趋势。”特斯拉表示，其持续的成本削减努力有助于抵消 Model 3 和 Model Y 等低价汽车销售导致的平均售价下降。</blockquote></p><p> Tesla has cut costs with the use of more Chinese parts including batteries. The company posted robust sales in China, where its Shanghai factory has surpassed the Tesla factory in Fremont, California, in terms of production.</p><p><blockquote>特斯拉通过使用包括电池在内的更多中国零部件来削减成本。该公司在中国的销售强劲，其上海工厂的产量已经超过了位于加州弗里蒙特的特斯拉工厂。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/bdf4574208dc79952acb2a1ca49c22b2\" tg-width=\"960\" tg-height=\"582\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla beats Q3 revenue estimates but supply-chain problems impacting factories<blockquote>特斯拉第三季度收入超出预期，但供应链问题影响工厂</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla beats Q3 revenue estimates but supply-chain problems impacting factories<blockquote>特斯拉第三季度收入超出预期，但供应链问题影响工厂</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-10-21 06:42</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Tesla Inc&nbsp;on Wednesday beat Wall Street expectations for third-quarter revenue on the back of record deliveries as the electric car maker navigated through a prolonged global shortage of chips and raw materials.</p><p><blockquote>电动汽车制造商特斯拉周三的第三季度收入超出了华尔街的预期，交付量创纪录，因为这家电动汽车制造商克服了全球芯片和原材料长期短缺的问题。</blockquote></p><p> Tesla said it aims to increase production in the fourth quarter from the previous quarter, adding that \"the magnitude of growth will be determined largely by outside factors.\"</p><p><blockquote>特斯拉表示，其目标是在第四季度比上一季度增加产量，并补充说“增长的幅度将在很大程度上取决于外部因素。”</blockquote></p><p> \"A variety of challenges, including semiconductor shortages, congestion at ports and rolling blackouts, have been impacting our ability to keep factories running at full speed,\" the company said.</p><p><blockquote>该公司表示：“包括半导体短缺、港口拥堵和轮流停电在内的各种挑战一直在影响我们保持工厂全速运行的能力。”</blockquote></p><p> Tesla, the world's most valuable automaker, has weathered the pandemic and the global supply-chain crisis better than rivals, posting record revenue for the fifth consecutive quarter in the July to September period, fueled by a production ramp-up at its Chinese factory.</p><p><blockquote>全球最有价值的汽车制造商特斯拉比竞争对手更好地抵御了疫情和全球供应链危机，在中国工厂产量增加的推动下，7 月至 9 月期间连续第五个季度实现创纪录的收入。</blockquote></p><p> Led by billionaire Elon Musk, Tesla faces challenges of maintaining its growth in the face of a prolonged chip shortage, with its factories starting production in Berlin and Texas this year.</p><p><blockquote>在亿万富翁埃隆·马斯克的领导下，面对长期的芯片短缺，特斯拉面临着维持增长的挑战，其在柏林和德克萨斯的工厂今年开始生产。</blockquote></p><p> Tesla shares, up about 23% this year, were down about 1.6% in extended trade late on Wednesday.</p><p><blockquote>特斯拉股价今年上涨约 23%，但在周三晚间的盘后交易中下跌约 1.6%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d998d6369e593952a4c3d57b9224c4a6\" tg-width=\"848\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Revenue rose to $13.76 billion from $8.77 billion a year earlier. Analysts had expected revenue of about $13.63 billion, according to IBES data from Refinitiv.</p><p><blockquote>收入从去年同期的 87.7 亿美元增至 137.6 亿美元。根据 Refinitiv 的 IBES 数据，分析师此前预计收入约为 136.3 亿美元。</blockquote></p><p> Tesla's automotive gross margin, excluding environmental credits, rose to 28.8%, from 25.8% the previous quarter.</p><p><blockquote>特斯拉不包括环境信用的汽车毛利率从上一季度的 25.8% 上升至 28.8%。</blockquote></p><p> Tesla has been raising prices in the United States, which helped cushion the impact of the supply-chain costs, analysts said.</p><p><blockquote>分析师表示，特斯拉一直在提高美国的价格，这有助于缓冲供应链成本的影响。</blockquote></p><p> \"Tesla's average selling price (ASP) of vehicles were higher than expected and the U.S. market drove that,\" said Gene Munster, managing partner at venture capital firm Loup Ventures, an investor in Tesla. Tesla said its ongoing cost-cutting efforts helped counter the declines in its ASPs stemming from sales of lower-priced vehicles like the Model 3 and Model Y.</p><p><blockquote>特斯拉投资者风险投资公司 Loup Ventures 的执行合伙人吉恩·蒙斯特 (Gene Munster) 表示：“特斯拉的汽车平均售价 (ASP) 高于预期，而美国市场推动了这一趋势。”特斯拉表示，其持续的成本削减努力有助于抵消 Model 3 和 Model Y 等低价汽车销售导致的平均售价下降。</blockquote></p><p> Tesla has cut costs with the use of more Chinese parts including batteries. The company posted robust sales in China, where its Shanghai factory has surpassed the Tesla factory in Fremont, California, in terms of production.</p><p><blockquote>特斯拉通过使用包括电池在内的更多中国零部件来削减成本。该公司在中国的销售强劲，其上海工厂的产量已经超过了位于加州弗里蒙特的特斯拉工厂。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/bdf4574208dc79952acb2a1ca49c22b2\" tg-width=\"960\" tg-height=\"582\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1181020907","content_text":"Tesla Inc on Wednesday beat Wall Street expectations for third-quarter revenue on the back of record deliveries as the electric car maker navigated through a prolonged global shortage of chips and raw materials.\nTesla said it aims to increase production in the fourth quarter from the previous quarter, adding that \"the magnitude of growth will be determined largely by outside factors.\"\n\"A variety of challenges, including semiconductor shortages, congestion at ports and rolling blackouts, have been impacting our ability to keep factories running at full speed,\" the company said.\nTesla, the world's most valuable automaker, has weathered the pandemic and the global supply-chain crisis better than rivals, posting record revenue for the fifth consecutive quarter in the July to September period, fueled by a production ramp-up at its Chinese factory.\nLed by billionaire Elon Musk, Tesla faces challenges of maintaining its growth in the face of a prolonged chip shortage, with its factories starting production in Berlin and Texas this year.\nTesla shares, up about 23% this year, were down about 1.6% in extended trade late on Wednesday.\n\nRevenue rose to $13.76 billion from $8.77 billion a year earlier. Analysts had expected revenue of about $13.63 billion, according to IBES data from Refinitiv.\nTesla's automotive gross margin, excluding environmental credits, rose to 28.8%, from 25.8% the previous quarter.\nTesla has been raising prices in the United States, which helped cushion the impact of the supply-chain costs, analysts said.\n\"Tesla's average selling price (ASP) of vehicles were higher than expected and the U.S. market drove that,\" said Gene Munster, managing partner at venture capital firm Loup Ventures, an investor in Tesla. Tesla said its ongoing cost-cutting efforts helped counter the declines in its ASPs stemming from sales of lower-priced vehicles like the Model 3 and Model Y.\nTesla has cut costs with the use of more Chinese parts including batteries. The company posted robust sales in China, where its Shanghai factory has surpassed the Tesla factory in Fremont, California, in terms of production.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":3071,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":183070016,"gmtCreate":1623296887635,"gmtModify":1631888757199,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579827147050987","authorIdStr":"3579827147050987"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/VIOT\">$Viomi Technology Co.(VIOT)$</a>rip the recent gains.. wwe're going back down","listText":"<a href=\"https://laohu8.com/S/VIOT\">$Viomi Technology Co.(VIOT)$</a>rip the recent gains.. wwe're going back down","text":"$Viomi Technology Co.(VIOT)$rip the recent gains.. wwe're going back down","images":[{"img":"https://static.tigerbbs.com/cffac8eb8ed4bff69988051e4dd4e71e","width":"1440","height":"2560"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/183070016","isVote":1,"tweetType":1,"viewCount":730,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}